MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint‐Ghislain, Manuel Rodrigues, Nicolas Penel et al.|European Journal of Cancer|2022Cited by 37
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafuspManuel Rodrigues, Shufang Renault, Toulsie Ramtohul et al.|Nature Communications|2024Cited by 30
<i>MBD4</i> deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study.Mathilde Saint‐Ghislain, Manuel Rodrigues, Lionnel Geoffrois et al.|Journal of Clinical Oncology|2022Cited by 2